Highlights
A collection of news and information related to Actos (drug) published by this site and its partners.
Displaying items 1-12 of 14
» View wsbtradio.com items only
1
2
Next >
-
Shop around for deals on prescription drugs
If your insurance has ever stopped covering a prescription drug or you don’t have coverage at all, you know how quickly costs can mount. Americans spent, on average, $758 out of pocket for medication in 2012, according to a recent Consumer Reports...Tags: Services and Shopping, Prices, Plavix (drug), Consumers, Clopidogrel (drug)
-
CONSUMER REPORTS: Big name drug savings
If you take Lipitor, Actos, or Lexapro, new generics of these and other big-name drugs could be a real money saver. But are you saving as much as you should? Consumer Reports has discovered just because you're buying a generic drug doesn't mean you're...
Tags: Walmart, Plavix (drug), Consumers, Prescription Drugs, Diabetes
-
Girardi | Keese
Given its deep bench of skilled trial attorneys—who include partner Amy Fisch Solomon —Girardi | Keese has pioneered litigation in the personal injury field, achieving more than $10 billion for its injured clients. “Amy is truly one of...
Tags: Vioxx (drug), Crime, Law and Justice, Laws, Trials, Avandia (drug)
-
What drugs are going generic this year and next
Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic...
Tags: Symptoms, Depression, Allergies, Plavix (drug), Sjogren's Syndrome
-
Robinson Calcagnie Robinson Shapiro Davis, Inc.
From defective cars to dangerous drugs to hazardous roadways, the firm has represented thousands of clients in individual suits, class actions and mass torts over the past four decades. Robinson Calcagnie Robinson Shapiro Davis, Inc. specializes in...
Tags: Disasters and Accidents, Machine Manufacturing, Commuting, Prozac (drug), Air and Space Accidents
-
|Story
-
Glaxo adds safety restrictions to Avandia label
ReutersWASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration...Tags: Food and Drug Administration, Crime, Law and Justice, Takeda Pharmaceutical Company Limited, Diabetes, Diseases and Illnesses
-
Patients kick the insulin habit through diet, exercise
By harnessing the power of lifestyle, the following people are managing their Type 2 diabetes without insulin, and in some cases without any medication at all. Some made the commitment when they were first diagnosed, but others reversed a condition that...Tags: Diets and Dieting, University of California, Berkeley, Yoga, Diseases and Illnesses, Health
-
Sulfonylureas for diabetes increase risk of heart disease and death, study finds
Booster ShotsSulfonylureas, the first family of oral drugs used for treating type 2 diabetes, increase the risk of death from all causes by as much as 61% compared with the newer drug metformin, British researchers have found. Some researchers have suspected...... -
For Diabetes Drug Avandia, Bad News Continues
Los Angeles TimesThe diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....Tags: Government Health Care, Crime, Law and Justice, U.S. Senate Committee on Finance, Heart Failure, Diabetes
-
The Avandia Dilemma
Staff WriterThe arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to stay on the market? Drug safety...Tags: Merck & Company Incorporated, Arthritis, Diabetes, Plastic Surgeons, Colleges and Universities
-
FDA: Avandia Should Stay With Restrictions
Los Angeles TimesFaced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...Tags: Brooklyn (New York City), Insulin, Heart Failure, Diabetes, Heart and Circulatory System
May 12, 2013
|Story| Herald Mail
Apr 15, 2013
|Story| WSBT-TV
Mar 25, 2013
|Story| Los Angeles Times
Aug 1, 2012
|Story| Chicago Tribune
Mar 26, 2012
|Story| Los Angeles Times
Nov 30, 2011
|Story| Los Angeles Times
Feb 7, 2011
|Story| Reuters
Oct 26, 2009
|Story| Los Angeles Times
Dec 4, 2009
| Los Angeles Times
Jun 29, 2010
|Story| Los Angeles Times
Jun 30, 2010
|Story| Health Portal
Jul 15, 2010
|Story| Los Angeles Times
Original site for Actos (drug) topic gallery.